| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.0038 | 1 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.0044 | 1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.0034 | 1 |